# PathoCapital

PathoCapital is a Private Equity based in Northbrook, United States.

## Overview

- **Organization type:** Private Equity
- **Headquarters:** Northbrook, United States
- **Region:** North America
- **Address:** Northbrook, IL, United States
- **Founded:** 2009
- **Assets under management:** Undisclosed
- **Website:** pathocapital.com

## Regulatory record

- **Reports private funds:** No

## About

PathoCapital is a privately owned investment company that focuses on healthcare investments. It has made 7 investments, including a Series B investment in Aptinyx on December 18, 2017. PathoCapital has also facilitated 3 portfolio exits, with ReliefBand Technologies being its most recent exit on October 17, 2022.

## Sectors

- Healthcare Services
- Digital Health

## Questions

### How does PathoCapital source deals?

The firm uses a proprietary direct-outreach model targeting managing partners of independent pathology groups. Rather than participating in broad auction processes run by investment banks, PathoCapital identifies regional laboratories facing succession challenges or capital-expenditure needs for digital pathology transitions, and negotiates bilateral transactions.

### Is PathoCapital structured as a private equity firm or a strategic healthcare operator?

PathoCapital functions as a hybrid: a financial sponsor that takes control positions but derives its post-acquisition value-creation plan almost entirely from operational expertise in lab management, CLIA compliance, and payer credentialing. The firm does not rely on high leverage or multiple arbitrage alone, distinguishing it from generalist lower-middle-market buyout funds.

## Related profiles

- [Patagonia Capital Partners](https://altss.com/profile/patagonia-capital-partners)
- [Paulos Holdings](https://altss.com/profile/paulos-holdings)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/pathocapital

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology